Accelerating the growth in life sciences is key to our strategy to becoming a faster-growing, more profitable, less cyclical company.

Accelerating the growth in life sciences is key to our strategy to becoming a faster-growing, more profitable, less cyclical company,

We will continue to drive for at least 10 to 12 percent annual earnings growth.

Our view of the global economy suggests several more quarters of low volume growth and continued price pressure, ... Lower raw material costs and more favorable currency comparison. combined with results from our productivity focus should all contribute to our ability to weather this cycle more favorably than in the past.

A community without accountability doesn’t stand a chance!

The office was not profitable and prospects for future growth at this site were, at best, suspect.